Translate page

Collage Cortes KrauseThe recently concluded ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy featured an exciting, cutting-edge, scientific program. This is a friendly reminder to attend the webinar with highlights of this meeting next Tuesday, October 8th at 13.00 CEST.

This live webinar is part of our ongoing iCMLf Conversations series
Your dial-in link for Zoom: https://us02web.zoom.us/j/85295994086

Expect highlights on new and often unpublished data, and the most innovative developments in CML – presented to you by Professors Jorge Cortes and Daniela Krause, both co-chairs of the conference. Some of the key sessions included new therapeutic approaches, TKI responses and biomarkers, progenitor cells and immunology, and the latest in blast phase CML treatments.

Promo 2024 JGM ConferenceWe're bringing you highlights from the conference with a summary of selected scientific sessions. Check back over the next couple of days for updates on more sessions.

🌟 Scientific Session: Top scoring abstracts 🌟

This Scientific Session presented six top-scoring abstracts selected by the meeting organisers. These presentations highlighted key advancements in understanding the mechanisms of disease progression, the clinical implications of mutations, and factors driving relapse after CML cessation.

During this session, the best biological abstract was awarded to Daniele Sarnello for his work on BNIP3 as a potential therapeutic target in hypoxic CML cells, while the best clinical abstract went to Kendra Sweet, who presented results of the SWOG trial on the addition of ruxolitinib to BCR::ABL1 TKIs.

iCMLf RDG Logo Latin AmericaContinuing our series of CML education events around the world, the iCMLf recently hosted three Regional Discussion Group meetings for Latin America. These webinars bring together physicians and scientists to discuss specific challenges of managing CML across Latin America. The sessions covered; the choice and order of TKIs managing chronic treatment effects, strategies for stopping CML therapy, and applying the ELN laboratory guidelines in low- and middle-income countries. The sessions were attended by over ​​130 attendees from 15 countries.

We are incredibly grateful for the time and input from all of the experts and for support from Novartis for these meetings, which allowed simultaneous translation in Spanish and Portuguese.

The discussions highlighted five key themes:

PSHWe’d like to invite you to a new series of iCMLf facilitated discussions to support the learning needs of CML physicians in Pakistan, in partnership with the Pakistan Society of Haematology.

See you in Prague 2September 2024 - As the ESH-iCMLf 26th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy approaches, we’re excited to share some of the highlights you can expect and opportunities to meet with us.

The three conference days from September 27 – 29 will be fully dedicated to CML, bringing together world-class experts, groundbreaking science from new insights into the biology of CML to the latest therapeutic strategies, and also invaluable networking opportunities for everyone involved in the field of CML.

We look forward to meeting many of you there in person! For those who cannot attend there will be meeting highlights following the conference and look out for our social media session updates over the conference days.

More details below…

Collage Cortes KrauseSeptember 2024 - We are pleased to announce the upcoming iCMLf Conversation, which will present the key takeaways from the ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy that is scheduled from September 27-29 in Prague.

Whether you attend the conference or not, we invite you to join us on Tuesday, October 8, 2024 at 13:00 CEST for a comprehensive summary of the conference highlights. Meeting co-chairs, Professor Jorge Cortes and Professor Daniela Krause, will cover significant clinical and biological insights, including new, often unpublished data on CML.

This live webinar is an excellent chance to stay informed and engage with the latest research in CML presented at this important CML conference.

Don’t miss this opportunity and mark your calendar.